NewMediaWire
Paid press release content from NewMediaWire. The StreetInsider.com news staff was not involved in its creation.
More NewMediaWire
View Older Stories View Newer Stories-
ABVC BioPharma Announces Enrollment Progress for ADHD Phase II Part 2 Clinical Study
-
Maison Luxe Establishes Kicks On Demand Subsidiary to Leverage Strong Relationships In Estimated $6 Billion Global Sneaker Resale Market
-
Medolife Rx in Discussions with a Major Infomercial Agency and Receives Exceptionally Positive Product Reviews
-
Innovative Designs Update to Shareholders
-
GZ6G Technologies Announces Disruptive Out-of-Home (OOH) Brand Sponsorship and Advertising Opportunities to Reach Consumer Audiences in Sports Venues and Other Locations
-
GGTOOR, Inc., (OTCMKTS:GTOR) Announces Management Report for the Week Ended May 28, 2022
-
Todos Medical to Present Final Data from the Tollovir Phase 2 Clinical Trial in Hospitalized COVID-19 Patients at the Personalized Medicine World Conference
-
Grove Inc. Upexi Division Launches Medicinal Mushroom Product Line Direct to Consumer and on Amazon
-
BrewBilt Manufacturing Hires Head of Sales as Revenue Share Expands
-
Emergency Response Technologies Inc, a Wholly Owned Subsidiary of ILUS International (Ilustrato Pictures International Inc), Confirms That It Has Acquired the Controlling Block of Wikisoft Corp. (OTCQ
-
Loop Kicks Off Their Biggest Summer Yet With Three New Specialty Channels Honoring Black Music Month, Pride Month and All The Best Music of Summer
-
BioAdaptives Sponsors COVID-19 Long Hauler Survey
-
BioLife Sciences Inc. Files Form 1-A with the Securities and Exchange Commission (SEC) to Raise Capital Under a Tier I Regulation A+ Offering
-
EF Hutton Appoints Michael G. King, Jr. as Managing Director, Head of Healthcare Research
-
Cavitation Technologies Receives International Purchase Orders for Low Pressure Nano Reactor System (LPN)
-
Todos Medical Reports Day 26 Update For Case Study #4
-
ABVC BioPharma Announces Enrollment Progress for ADHD Phase II Part 2 Clinical Study
-
Maison Luxe Establishes Kicks On Demand Subsidiary to Leverage Strong Relationships In Estimated $6 Billion Global Sneaker Resale Market
-
Endexx to Present at the LD Micro Invitational XII Four Seasons Westlake Village June 7-9th
-
Medolife Rx in Discussions with a Major Infomercial Agency and Receives Exceptionally Positive Product Reviews
-
Innovative Designs Update to Shareholders
-
GZ6G Technologies Announces Disruptive Out-of-Home (OOH) Brand Sponsorship and Advertising Opportunities to Reach Consumer Audiences in Sports Venues and Other Locations
-
Forza Innovations Inc. Announces Sustainable Origins Strategic Update
-
Peapack Private Wealth Management Promotes Nicole Bonanno to Senior Managing Director, Director of Client Service
-
Medical Marijuana, Inc. Subsidiary Kannaway Celebrates Recent Federal Court Ruling on Delta-8 THC; Launches New Hemp Products
-
GGTOOR, Inc., (OTCMKTS:GTOR) Announces Management Report for the Week Ended May 28, 2022
-
BioCorRx to Present at the LD Micro Invitational XII on June 7th
-
Timber Pharmaceuticals Receives FDA Breakthrough Therapy Designation for TMB-001 for the Treatment of Congenital Ichthyosis
-
Reliance Global Group Appoints Senior Corporate Finance Executive William Lebovics as Chief Financial Officer
-
CBD Global Issues Second Bi-Weekly Report and Provides Update on Delayed Annual Filings
-
OTC: ILUS, ILUS International (Ilustrato Pictures International Inc) Agrees Terms With an Acquisition Delivering Upwards of $100 Million in Annual Revenue
-
EF Hutton Appoints Vince Curatola as Managing Director, Capital Markets Services
-
BioCorRx and 2B3D to Pilot First-of-its-Kind PTSD and Addiction Treatment Solutions for Veterans in Metaverse Setting
-
Todos Medical Releases Corporate Update
-
Hop-on Presents Digitalage at VidCon 2022
-
D3eSports Proudly Announces First Hotel Resort Simulator Destination in Partnership with Newly Launched Team Jamaica
-
Hemp, Inc.'s King of Hemp CBD-CBG-CBN Natural Sleep Aid Capsules in Stock and On Sale
-
GeoVax Receives Notice of Allowance for Cancer Vaccine Patent in China
-
Texas Mineral Resources Adds Navajo Transitional Energy CEO Vern Lund to Board of Directors
-
Aemetis Signs Agreement with Alaska Airlines to Supply 13 Million Gallons of Sustainable Aviation Fuel
-
Sono-Tek Announces Record Sales and Backlog for Fiscal Year 2022, Another Record Year for Sales Expected for Fiscal Year 2023, and Provides First Quarter Fiscal 2023 Sales Guidance
-
Medical Marijuana, Inc. Subsidiary HempMeds Brasil Celebrates Feature in Forbes
-
Rising Uranium Prices Precursor to Demand for US Nuclear Products
-
Prestigious Researchers to Provide Consulting Services in Connection with ABVC BioPharma's Depression Medicines
-
Todos Medical Releases Corporate Update
-
Todos Medical to Present Final Data from the Tollovir Phase 2 Clinical Trial in Hospitalized COVID-19 Patients at the Personalized Medicine World Conference
-
Hop-on Presents Digitalage at VidCon 2022
-
D3eSports Proudly Announces First Hotel Resort Simulator Destination in Partnership with Newly Launched Team Jamaica
-
Grove Inc. Upexi Division Launches Medicinal Mushroom Product Line Direct to Consumer and on Amazon
-
Medical Marijuana, Inc. Launches Pharma Subsidiary in Brazil; Expands Access to CBD Products in Pharmacies
